Pharmaceutical firm posted a 4.3% decline in net profit, to Rp1.98 trillion in 2015, from Rp2.06 trillion in 2014, mostly due to weak top line growth and rupiah depreciation. Net profit margin fell to 11% last year from 11.9% in 2014. Indicative consolidated net sales, however rose 3% to Rp17.9 trillion last year, compared to Rp17.4 trillion in 20914.To subscribe please click here
